IL17A and COVID-19: Along the same lines, patients with long-standing COVID-19 have been reported to have a pro-inflammatory cytokine profile characterized by higher levels of IL-1β, IL-6, IL-13, IL-17A, TNFα, IFNγ-induced protein-10 (IP-10), and G-CSF [100,101,102].